21 Feb 2020 Notably, Aerie's stock has slumped 50.3% in the past year compared with the industry's decline of 3.4%. The company reported a loss of 96  20 Feb 2020 Aerie Pharmaceuticals (AERI) Reports Q4 Loss, Tops Revenue Estimates. Zacks Equity Research February 20, 2020. Trades from $1.

Aerie Pharmaceuticals, Inc. - AERI - Stock Price Today - Zacks View Aerie Pharmaceuticals, Inc. AERI investment & stock information. Get the latest Aerie Pharmaceuticals, Inc. AERI detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. AERI: Aerie Pharmaceuticals, Inc. - Zacks Investment Research AERI: Aerie Pharmaceuticals, Inc. broker recommendations. Get the latest broker recommendations from Zacks Investment Research. All News for AERI : Aerie Pharmaceuticals, Inc. - Zacks.com Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

AERI Stock Price | Aerie Pharmaceuticals Inc. Stock Quote ...

Mar 21, 2020 · It has been about a month since the las t earnings report for Aerie Pharmaceuticals (AERI). Shares have lost about 40.5% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is Aerie due for a breakout? Aerie Pharmaceuticals (NASDAQ:AERI), Endo Health Solutions ... Mar 27, 2018 · The performance of the drug industry in first-quarter 2018 has been an encouraging one with quite a few companies' beatings both earnings as well as revenue estimates. The Aerie Pharmaceuticals Inc (NASDAQ:AERI) Expected to Post ...

Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

AERI: Aerie Pharmaceuticals, Inc. - Zacks Investment Research AERI: Aerie Pharmaceuticals, Inc. broker recommendations. Get the latest broker recommendations from Zacks Investment Research. All News for AERI : Aerie Pharmaceuticals, Inc. - Zacks.com

Aerie Pharmaceuticals (AERI) came out with a quarterly loss of $0.96 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to loss of $0.92 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of …

Aerie Pharmaceuticals (NASDAQ:AERI) Downgraded by Zacks ... Zacks Investment Research cut shares of Aerie Pharmaceuticals (NASDAQ:AERI) from a buy rating to a hold rating in a report issued on Monday morning, Zacks.com reports. The firm currently has $23.00 price objective on the stock. According to Zacks, “Aerie reported mixed results for the fourth quarter of 2019, as the loss came in wider […] Aerie (AERI) Beats on Q2 Earnings & Sales, Lowers Guidance

Aerie Pharmaceuticals, Inc. (AERI) Stock Price, Quote ...

AERI Stock Price | Aerie Pharmaceuticals Inc. Stock Quote ... AERI | Complete Aerie Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Aerie Pharmaceuticals, Inc. (AERI) Stock Price, Quote ... Find the latest Aerie Pharmaceuticals, Inc. (AERI) stock quote, history, news and other vital information to help you with your stock trading and investing. Aerie Pharmaceuticals, Inc. Common Stock (AERI) Earnings ... Aerie Pharmaceuticals, Inc. Common Stock (AERI) Earnings Report Date. Earnings announcement* for AERI: May 05, 2020 Our vendor, Zacks Investment Research, might revise this date in the future AERI | Aerie Pharmaceuticals Inc. Profile | MarketWatch

Aerie Pharmaceuticals Inc (NASDAQ:AERI) Expected to Post ... Wall Street analysts expect Aerie Pharmaceuticals Inc (NASDAQ:AERI) to post $19.39 million in sales for the current fiscal quarter, according to Zacks. Five analysts have made estimates for Aerie Pharmaceuticals’ earnings. The highest sales estimate is $20.74 million and the lowest is $17.00 million. Aerie Pharmaceuticals posted sales of $14.46 million in the same quarter […] Aerie Pharmaceuticals (AERI) Reports Q4 Loss, Tops Revenue ... Aerie Pharmaceuticals (AERI) came out with a quarterly loss of $0.96 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to loss of $0.92 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of … Aerie: 4Q Earnings Snapshot The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.